See other companies on Welcome to the Jungle
Arterys
Medical imaging AI platform
- 21-100 employees
- Healthcare
- B2B
- Artificial Intelligence
- Enterprise
- Computer Vision
- SaaS
- MedTech
- Lower Pacific Heights, San Francisco, CA
Jump to section
Company mission
The Arterys mission is to transform healthcare by reducing subjectivity and variability in clinical diagnosis.
Our take
Like the story of many technologies, AI in medicine has been a story of gradual and then sudden growth. Now, applications of machine learning are being seen across medical departments. One leading area has been its application to medical imaging, of which Arterys is at the forefront.
Arterys offers an AI-based platform which dramatically reduces the time required by doctors to detect conditions from images resulting from scans. For example, Pediatric cardiovascular diseases are most often detected using ultrasound, which offers only a partial view of the heart without blood flow quantifications or MRI, requiring many hours when a child must be secured to a scanning table.
The team hopes to create an automated, intelligent and zero-footprint medical imaging analytic cloud platform for doctors to have direct access to lifesaving images and unleash real-world clinical data to make healthcare more data-driven and accurate.
Its flagship product, Cardio AI, targets structural heart disease but Arterys has plans for products examining brain and lung imageries and it has a special long-term emphasis on the ideas of collective intelligence and cloud-based AI.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Variety of medical, dental and vision options that allow employees and their dependents to choose what works best for them
Company values
- Honesty: We communicate with candor
- Excellence: We set the bar high
- Accountability: We work together to deliver on commitments
- Respect: We treat others as we want to be treated
- Trust: We are confident in each other’s contributions
Funding (last 2 of 5 rounds)
May 2020
$28m
SERIES C
Nov 2017
$30m
SERIES B
Total funding: $78.7m
This company has top investors
Leadership
John Axerio-Cilies
(CEO)PhD in Engineering, Stanford University. PRIE Program, Stanford Graduate School of Business. Experienced engineer in automobile and medical contexts.